Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is -8.58% vs -12.29% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -66.12% vs -25.85% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -53.63% vs -50.60% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -41.18% vs 54.55% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Guiyang Xintian Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 21.32% vs -14.54% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -8.58% vs -12.29% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 550.00% vs -61.90% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -66.12% vs -25.85% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -16.25% vs -13.04% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -53.63% vs -50.60% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -13.04% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -41.18% vs 54.55% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






